INTELLIGENCE IN ACTION

Laws Requiring the E-Prescribing of Opioids Have Gained Momentum, but Prescriber Adoption is Playing Catch Up

January 02, 2019

The SUPPORT for Patients and Communities Act, which Congress passed and President Trump signed into law in October, mandates the use of electronic prescribing of controlled substances (EPCS) for all controlled substances under Medicare Part D by January 1, 2021.

EPCS is a critical tool in the nation's response to the epidemic. It eliminates paper prescriptions, which can be stolen, forged or altered, and gives prescribers electronic access to a patient’s prescription history to help identify potential overuse or abuse. In addition, there are other benefits, including enhanced security, privacy and prescribing flexibility, as well as improved workflow efficiency for prescribers and pharmacists alike.

Policymakers clearly see the need to leverage EPCS in the fight against opioid abuse, as the continued acceleration of EPCS legislation at the state level demonstrates. In 2018, eight more states passed mandates--Arizona, California, Iowa, Massachusetts, New Jersey, Oklahoma, Pennsylvania and Tennessee—bringing the total number of states with EPCS mandates to 15. Of that total, the mandates in Arizona, New Jersey and Pennsylvania become effective in 2019—with Arizona’s beginning the very first day of the new year. New Jersey’s mandate applies to EHR vendors, not prescribers or pharmacists. Michigan and Illinois have now introduced EPCS bills, and industry experts expect nearly twenty more states to pursue similar legislation in 2019.

These mandates have driven an increase in prescriber enablement across the nation. Maine, whose prescriber enablement hovered in the single digits before its law went into effect in July 2017, saw a rate of 69 percent by November 2018.

Still, we have some work to do. While more than 90 percent of non-controlled substances were prescribed electronically nationwide in 2017, just 21 percent of controlled substances were. That’s too low when so many lives are at stake.

However, it’s encouraging to see electronic health record (EHR) vendors taking action to help spur EPCS utilization among prescribers. In the past year, Cerner has seen a nearly 52 percent increase in EPCS transactions across prescribers using their EHR.

Prescribers should visit www.GetEPCS.com to learn how to get started today. And check out our interactive map (updated monthly) to see where each state stands in terms of EPCS enablement for both prescribers and pharmacies, as well as relevant policy developments.

Related Articles

November 11, 2019

50 Days and Counting: Take These Necessary Steps to Meet EPCS Requirements

Fraud and abuse are prevalent in the world of prescription painkillers. In 2017, a total of 61,311 people died from drug overdoses – with an estimated 40% from prescription opioid medicine. This is 61,311 too many. Opioid diversion is a significant cause of opioid misuse, with between 3% and 9% of diverted drugs tied to fraud or forgery of paper prescriptions.

Read more...
October 22, 2019

Now Trending: EPCS Among Physicians and Medicare Part D Patients

As we approach the one-year anniversary of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities (SUPPORT) Act, I am optimistic about the direction of a key provision outlined in the legislation, that is, the use of electronic prescribing of controlled substance (EPCS) among Medicare Part D providers.  Read more...
July 30, 2019

Lessons Learned: How Connecticut Implemented an EPCS Requirement That Was Effective and Embraced by the Medical Community

Connecticut’s Electronic Prescribing of Controlled Substances (EPCS) requirement came into effect in January 2018. As Drug Control Director, I often serve as an advisor to state legislators who want to ensure the bills they draft are effective once they become law, so I was very active in the 2017 legislative session. While crafting this bill, we looked at how other states managed implementation of EPCS and worked closely with medical professionals to ensure that our legislation was thoughtful. We knew we had to consider the day-to-day operations of regulators and medical professionals, and ultimately what was best for patients.

Read more...

INTELLIGENCE IN ACTION, DELIVERED TO YOUR INBOX